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Programmed cell death (PCD), or apoptosis, is initiated in response to various stimuli, including virus
infection. Bovine herpesvirus 1 (BHV-1) induces PCD in peripheral blood mononuclear cells at the G0/G1
phase of the cell cycle (E. Hanon, S. Hoornaert, F. Dequiedt, A. Vanderplasschen, J. Lyaku, L. Willems, and
P.-P. Pastoret, Virology 232:351–358, 1997). However, penetration of virus particles is not required for PCD (E.
Hanon, G. Meyer, A. Vanderplasschen, C. Dessy-Doize, E. Thiry, and P. P. Pastoret, J. Virol. 72:7638–7641,
1998). The mechanism by which BHV-1 induces PCD in peripheral blood mononuclear cells is not understood,
nor is it clear whether nonlymphoid cells undergo PCD following infection. This study demonstrates that
infection of bovine kidney (MDBK) cells with BHV-1 leads to PCD, as judged by terminal deoxynucleotidyl-
transferase-mediated dUTP-biotin nick end labeling, DNA laddering, and chromatin condensation. p53 ap-
pears to be important in this process, because p53 levels and promoter activity increased after infection.
Expression of proteins that are stimulated by p53 (p21Waf1 and Bax) is also activated after infection. Cleavage
of Bcl-xL, a protein that inhibits PCD, occurred after infection, suggesting that caspases (interleukin-1b-
converting enzyme-like proteases) were activated. Other caspase substrates [poly(ADP-ribose) polymerase and
actin] are also cleaved during the late stages of infection. Inhibition of caspase activity delayed cytotoxic
activity and virus release but increased the overall virus yield. Taken together, these results indicate that
nonlymphoid cells undergo PCD near the end of productive infection and further suggest that caspases
enhance virus release.
Bovine herpesvirus 1 (BHV-1) belongs to the Alphaherpes-
virinae subfamily and is a significant viral pathogen of cattle
(reviewed in reference 39). Acute infection leads to conjunc-
tivitis, tracheitis, and upper respiratory tract infections and can
induce a complex upper respiratory infection called shipping
fever. Although BHV-1 is not the sole infectious agent asso-
ciated with shipping fever, it initiates the disorder by immuno-
suppressing infected cattle (reviewed in reference 84). Conse-
quently, secondary bacterial infections can cause pneumonia.
Like other members of the Alphaherpesvirinae subfamily, BHV-1
establishes a latent infection in sensory ganglionic neurons
(reviewed in reference 39). Viral DNA persists in sensory neu-
rons for the lifetimes of infected cattle but can periodically
reactivate. Infection of permissive cells by BHV-1 leads to
rapid cell death and virus spread. Viral gene expression is
temporally regulated by two immediate-early (IE) transcrip-
tion units (75, 77, 92, 93). IE gene expression is stimulated by
a virion component (bTIF) which interacts with a cellular tran-
scription factor (Oct-1), and subsequently this protein complex
binds TAATGARAT motifs present in IE promoters (52). It is
generally agreed that tissue-specific factors mediate latency
and pathogenesis by influencing viral gene expression.
There are two types of cell death, necrosis and programmed
cell death (PCD) (apoptosis), and they differ in their morpho-
logical and biochemical characteristics (reviewed in reference
48). PCD occurs during embryogenesis, tissue differentiation,
aging, or tumor regression (reviewed in reference 86). PCD
can be triggered by a variety of stimuli, including viral infection
(reviewed in reference 79), growth factor withdrawal (26), and
DNA damage (reviewed in reference 25). Cells exhibit nuclear
fragmentation, chromatin condensation, cleavage of DNA into
nucleosomal oligomers, cell shrinkage, and appearance of ap-
optotic bodies which are engulfed by surrounding cells (re-
viewed in references 91 and 95).
The tumor suppressor protein p53 monitors cell cycle check-
points (40), senses DNA damage (42), assembles DNA repair
machinery (89), modulates gene amplification (96), and acti-
vates PCD (78, 97). The ability of p53 to induce PCD is crucial
for tumor suppressor function (15, 28, 47, 81, 97). However,
whether p53’s ability to activate gene expression is required for
PCD is controversial (6, 70, 88). A p53-inducible gene product,
p21Waf1, a component of p53-dependent G1 arrest, is dispens-
able for p53-dependent PCD but is required for cell cycle
arrest (reviewed in references 1, 17, 22, 41, and 49). A link
between p53 induction and activation of interleukin-1b-con-
verting enzyme-like proteases, or caspases, following DNA
damage has also been established (9, 45, 71). p53-independent
mechanisms of PCD also exist, and they usually lead to caspase
activation.
Many viruses induce PCD when cultured cells are infected
(reviewed in references 67, 79, and 82a). Premature PCD of
infected cells reduces burst size and thus prevents spread.
Members of the Alphaherpesvirinae subfamily, e.g., herpes sim-
plex virus type 1 (HSV-1), varicella-zoster virus, or BHV-1,
induce PCD after infection of cultured cells (24, 30–32, 43, 72).
BHV-1-induced PCD occurs at the G0/G1 phase of the cell
cycle in cultured peripheral blood mononuclear cells (PBMC)
(24, 31). Since inactivated BHV-1 induced PCD of PBMC (30,
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32), it is possible that PCD was a result of PBMC activation
(90) and not a direct result of infection. Furthermore, it is not
clear whether PCD occurs when fibroblasts or epithelial cells
are infected with BHV-1.
In this study, we analyzed BHV-1-induced PCD in Madin-
Darby bovine kidney (MDBK) cells. Following infection of
MDBK cells, PCD occurred during the late stages of infection.
In contrast to the case for PBMC, PCD did not occur when
virus preparations were inactivated by Psoralen or heat. Virus-
induced PCD appeared to occur in a p53-dependent manner.
Processing and activation of caspase 2 and cleavage of poly-
(ADP-ribose) polymerase (PARP), actin, and Bcl-xL occurred
after infection, suggesting that caspases were activated. Inhi-
bition of caspase activity increased virus yield but delayed or
inhibited virus release.
MATERIALS AND METHODS
Cells and virus. MDBK cells or CV-1 cells (African green monkey kidney
cells; American Type Culture Collection, Rockville, Md.) were grown in Earle’s
modified Eagle’s medium supplemented with 10% fetal calf serum. The Cooper
strain of BHV-1 was obtained from the National Veterinary Services Laboratory,
Animal and Plant Health Inspection Services (Ames, Iowa). MDBK cells were
infected with 5 PFU of BHV-1/cell.
BHV-1 was inactivated by photochemical treatment as described previously
(30). Briefly, Psoralen (catalogue no. 8399; Sigma) was dissolved in dimethyl
sulfoxide (DMSO) to a final concentration of 200 mg/ml. This stock was added to
the viral suspension (107 50% tissue culture infective doses/ml) to a final con-
centration of 1 mg/ml. This viral suspension was then irradiated with 254-nm-
wavelength UV (UVP Products, San Gabriel, Calif.). Alternatively, virus was
inactivated by boiling the viral suspension for 10 min.
Antibodies and plasmids. Antibodies for p53 (sc-99 and sc-100), Bcl-2 (sc-
783), Bax (sc-526), p21Waf1/Cip1 (sc-528), Bcl-xL (sc-1690), actin (sc-1616), and
caspase 2 (sc-626) were purchased from Santa Cruz Biotechnology (Santa Cruz,
Calif.). PARP antibodies (SA252) were purchased from BioMol (Plymouth
Meeting, Pa.).
A chloramphenicol acetyltransferase (CAT) plasmid containing the murine
p53 promoter, p0.7CAT (p53CAT), was provided by V. Rotter (University of
South Carolina). Plasmid pA10CAT contains the simian virus 40 early promoter
and was obtained from B. Howard (National Institutes of Health). The plasmid
containing the intact human p21Waf1/Cip promoter, pWWPCAT, was obtained
from B. Vogelstein (Johns Hopkins University). pSV2-b-gal was purchased from
Clontech, Palo Alto, Calif.
TUNEL assay. The terminal deoxynucleotidyltransferase-mediated dUTP-bi-
otin nick end-labeling (TUNEL) technique detects endonucleolytically cleaved
DNA by the addition of labeled dUTP to DNA ends by terminal transferase.
MDBK cells grown on coverslips were infected with 5 PFU/cell and stained with
an in situ cell death detection kit (catalogue no. 1684 809; Boehringer Mann-
heim) according to the manufacturer’s instructions.
Hoechst 33342 staining. Monolayers of MDBK cells grown on glass coverslips
were infected with BHV-1 at 5 PFU/cell. At various times postinfection (p.i.),
cells were washed with phosphate-buffered saline (PBS), fixed with ice-cold
FIG. 1. BHV-1 induces PCD in MDBK cells. MDBK cells were infected with BHV-1 for 48 h. Mock-infected cells served as a control. Hoechst 33342 staining was
observed under UV light. Magnifications, 3800 for Hoechst staining and 3200 for TUNEL assay. Arrows point to TUNEL-positive cells or to nuclei that contain
condensed chromatin.
TABLE 1. Primers used in this study
Transcript Primers
p53 59 CCGAGGCCGGCTCTGAGTATACCACCATCC 39 (1)
59 CTCATTCAGCTCCCGGAACATCTCGAAGCG 39 (2)
Bcl-2 59 GTCGCTACCGTCGTGACTT 39 (1)
59 CAGCCTCCGTTATCCTGGA 39 (2)
Actin 59 GTGGGCCGCTCTAGGCACCAA 39 (1)
59 CTCTTTGATGTCACGCACGATTTC 39 (2)
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methanol-acetone (1:1, vol/vol) for 10 min at 220°C, and then washed once with
PBS. Nuclei were stained with Hoechst 33342 (catalogue no. B-2261; Sigma) (0.5
mg/ml in PBS) for 10 min in the dark, washed once with PBS, and mounted on
slides in glycerol-citric acid phosphate buffer (9:1, vol/vol), pH 4.1. Cells were
visualized under UV with a fluorescence microscope (Microphot; Nikon, Mell-
ville, N.Y.).
Analysis of high-molecular-weight DNA after infection. Monolayers of MDBK
cells were grown in 100-mm-diameter plates and then infected with 5 PFU of
BHV-1 per cell. DNA from uninfected or infected cells was extracted (43). Five
micrograms of each DNA sample was electrophoresed on a 1.5% agarose gel
containing 0.1 mg of ethidium bromide per ml. The DNA was visualized under
UV light, and the sizes of the respective amplified products were estimated
by comparing the mobilities with a 100-bp ladder (catalogue no. 15628-019;
GIBCO-BRL).
Western blot analysis. Extract from infected or uninfected cells was prepared
as described previously (33). Approximately 20 mg of extract was resolved by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
transferred onto Immobilon (Millipore) membranes according to the manufac-
turer’s instructions. Membranes were probed with the indicated antibodies, and
Western blots were developed by chemiluminescence (ECL1 plus, RPN 2132;
Amersham). The sizes of the proteins on SDS-PAGE were estimated by using
Amersham molecular weight markers (catalogue no. RPN 756).
RNA PCR analysis. Total RNA from uninfected or infected cells was extracted
by using RNAgents (total RNA isolation system from Promega; catalogue no.
Z5110) according to the manufacturer’s instructions. Three micrograms of total
RNA was reverse transcribed by using a random primer (Invitrogen) with reverse
transcriptase from GIBCO-BRL according to the manufacturer’s instructions.
The first-strand cDNA was amplified by using the primers described in Table 1.
The cDNA was amplified in a Hybaid thermal cycler under the following con-
ditions: 95°C for 1 min, 60°C for 1 min, 72°C for 2 min, and 72°C for 7 min to
allow for final extension. Amplified products were resolved on 2% agarose gels
(NuSieve). The sizes of the amplified products were estimated by using fX174
replicative DNA cleaved with HaeIII DNA (New England Biolabs).
Immunoprecipitation. Uninfected or infected MDBK cells were rinsed twice
with methionine-free Dulbecco modified Eagle medium (DMEM) (GIBCO-
BRL) and incubated in methionine-free DMEM at 37°C for 30 min. The cells
were then incubated (37°C for 4 h) with 200 mCi of [35S]methionine (Amer-
sham) in 2 ml of methionine-free DMEM supplemented with 1% dialyzed
fetal bovine serum. The labeled cells were then washed with ice-cold PBS.
One milliliter of lysis buffer (50 mM Tris-HCl [pH 7.3], 75 mM NaCl, 0.5%
Nonidet P-40, 1 mM phenylmethylsulfonyl fluoride [PMSF], 1 mM leupeptin,
1 mM apopain) was added directly to the dish and rocked for 30 min at 4°C.
Cells were scraped into a microcentrifuge tube and centrifuged at 10,000 3
g for 10 min at 4°C.
Cell lysate (500 ml) prepared from metabolically labeled cells was precleared
with normal mouse serum for 30 min, followed by precipitation with a p53 or
actin antibody overnight at 4°C. Twenty microliters of protein A-agarose beads
(Santa Cruz) was incubated for 30 min at 4°C, and the beads were subsequently
washed three times (each) with 1 ml of PBS containing 1, 0.5, or 0.05% Triton
X-100. The beads were then suspended in 50 ml of 23 SDS loading buffer and
boiled for 10 min. Proteins were separated by SDS-PAGE and visualized by
fluorography with En3Hance (Amersham).
Extraction of PARP. Infected or uninfected cells were washed twice with
ice-cold PBS and then once with ice-cold buffer A (100 mM Tris-HCl [pH 7.4],
10 mM MgSO4, 500 mM sucrose, 10 mM PMSF, 0.5 mg of leupeptin per ml, 0.75
mg of pepstatin per ml, and 5 mg of antipain per ml). Cells were permeabilized
by incubation on ice for 20 min with buffer B (100 mM Tris-HCl [pH 7.4], 10 mM
MgSO4, 500 mM sucrose, 10 mM PMSF, 1% Nonidet P-40; 0.25 mg of leupeptin
per ml, 0.35 mg of pepstatin per ml, and 50 mg of antipain per ml). PARP was
extracted from permeabilized cells by incubation with cold buffer C (200 mM
K2HPO4, 100 mM Tris-HCl [pH 7.4], 10 mM MgSO4, 500 mM sucrose, 10 mM
PMSF, 0.5 mg of leupeptin per ml, 0.75 mg of pepstatin per ml, and 5 mg of
antipain per ml) on ice for 20 min. The extract was centrifuged at 2,000 3 g for
10 min at 4°C, and the supernatant was collected and mixed with 4 volumes of
urea loading buffer (62.5 mM Tris-HCl [pH 6.8], 6 M urea, 10% glycerol, 2%
SDS, 0.00125% bromophenol blue, and 5% b-mercaptoethanol).
FIG. 2. Inactivated BHV-1 does not induce chromatin condensation in MDBK cells. BHV-1 was treated with Psoralen or was heat inactivated as described in
Materials and Methods (magnification, 3400). As a positive control, a similar amount of untreated BHV-1 was used to infect cultures of MDBK cells (magnification,
3800). At 48 h p.i., Hoechst 33342 staining was performed and the cells were observed under UV light. Arrows point to a nucleus that contains condensed chromatin.
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CAT assay. MDBK cells grown in 60-mm-diameter dishes were transfected
with 1 mg each of p0.7CAT or pWWPCAT and pSV2-b-gal with Superfect
reagent (Qiagen) according to the manufacturer’s instructions. Cells were in-
fected with BHV-1 (5 PFU/cell) at 24 h after transfection. Cells were harvested at 24,
36, or 48 h p.i., and CAT assays were performed as previously described (19). The
amounts of extract used to measure CAT activity were adjusted based on b-galac-
tosidase (b-gal) activity. b-gal activity was measured by using ortho-nitrophenyl-b-
D-galactopyranoside (ONPG) (Sigma) as a substrate in colorimetric assays (57).
In vitro reconstitution of PCD. (i) Preparation of cell extracts. Uninfected or
infected MDBK cells were washed once with PBS and then with cell extract
buffer [50 mM piperazine-N,N9-bis(2-ethanesulfonic acid) (PIPES) (pH 7.4),
50 mM KCl, 5 mM EGTA, 2 mM MgCl2, 1 mM dithiothreitol (DTT), 10 mM
cytochalasin B, and 1 mM PMSF]. The cells were harvested, swelled by
treatment with an equal volume of cell extract buffer on ice for 20 min, and
then lysed in a Dounce homogenizer (Wheaton) by 20 strokes with a type B
pestle. The homogenate was centrifuged at 4°C for 20 min at 14,000 rpm in a
FIG. 3. Infection induces DNA degradation and reduces cell viability. (A) Agarose gel electrophoresis of DNA extracted from MDBK cells at 24, 36, or 48 h p.i.
Lane 0, DNA prepared from mock-infected cells; lane M, 100-bp ladder. Numbers on the left indicate base pairs. (B) Measurement of cell viability as judged by trypan
blue staining. Data from one of two experiments is shown.
FIG. 4. Analysis of p53 after infection. MDBK cells were infected with BHV-1 for the indicated times (hours p.i.). Mock-infected cells (lanes M) served as a control.
(A and B) Western blot analysis of p53 and actin in infected cells (A) and fluorography of 35S-labeled p53 and actin (B). Immunoprecipitation was carried out with
an antibody that specifically recognizes p53 or actin. Arrows on the right of each panel indicate the position of p53 or actin. The numbers to the left of each panel
represent the positions of protein markers (in kilodaltons). (C) RNA PCR analysis with primers specific for p53 or b-actin. Three micrograms of total RNA was reverse
transcribed with Superscript reverse transcriptase, and the cDNA was amplified by PCR. The arrows on the right represent the positions of the amplified cDNA.
Numbers on the left are the positions of fX174 DNA digested with HaeIII (in base pairs). (D) A mouse p53 promoter construct (p53CAT) or pA10CAT was
cotransfected with pSV2-b-gal into MDBK cells with Superfect transfection reagent from Qiagen. Twenty-four hours after transfection, the cells were infected with 5
PFU/cell. Cells were harvested at the indicated times p.i., and CAT activity was measured. The amount of extract used to measure CAT activity was adjusted based
on b-gal activity in the respective samples. Ac-CM, acetylated chloramphenicol.
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Beckman (Palo Alto, Calif.) Avanti 30 centrifuge, and the supernatant was stored
at 270°C.
(ii) Preparation of nuclei. Confluent monolayers of CV-1 cells were washed
with PBS, and nuclei were prepared (35). The nuclei were suspended in storage
buffer (10 mM PIPES [pH 7.4], 80 mM KCl, 20 mM NaCl, 250 mM sucrose, 5
mM EGTA, 1 mM DTT, 0.5 mM spermidine, 0.2 mM spermine, 1 mM PMSF,
and 50% glycerol) and stored in aliquots at 270°C.
(iii) Cell-free apoptosis. Cell extract (75 mg) was incubated with 2 3 105 nuclei
in 10 mM HEPES (pH 7.4)–50 mM NaCl–2 mM MgCl2–5 mM EGTA–1 mM
DTT and incubated at 37°C for 1 h. The caspase inhibitor Z-VAD-FMK (25 mM)
was added to extracts prior to incubation.
(iv) Hoechst staining of nuclei. Four or five microliters of the cell-free apo-
ptosis reaction mixture was stained with 2 ml of 10 mM Hoechst 33342 (Sigma)
in formalin on a glass slide for 2 to 3 min in the dark. The slides were washed for
2 min with water, air dried, and baked for 60 min at 50°C. Slides were mounted
with 0.5 mg of Canada balsam (catalogue no. C-1795; Sigma) per ml and ob-
served under UV light with a fluorescence microscope (Diaphot; Nikon).
Effect of caspase inhibitors on virus release and yield. The following caspase
inhibitors were purchased from Calbiochem (La Jolla, Calif.) and used for these
studies: caspase 3 inhibitor II (Z-DEVD-FMK; catalogue no. 264155), caspase 1
inhibitor I (Ac-YVAD-CHO; catalogue no. 400010), and caspase inhibitor I
(Z-VAD-FMK; catalogue no. 627610).
For the virus production assay, 25 mM Z-VAD-FMK was added at 6 and 24 h
p.i., due to the short half-life of the peptide. Cells and medium were harvested
at 48 h p.i. Nearly all cells which were infected but not treated with Z-VAD-FMK
were rounded and detached from the plate at 48 h p.i. For total virus yield, cells
plus medium were frozen and thawed three times to release virus particles. The
yield of infectious virus was determined by estimating the 50% end points (68).
For the virus release assay, cells and medium were separated by centrifugation
(1,000 rpm for 3 min) in a CR412 centrifuge (Jouan, St. Herblain Cedex,
France). The resulting cell pellet was frozen, thawed three times, and suspended
in 1 ml of DMEM. Infectious virus yields in the medium or in the cell pellet were
determined separately. The percent virus release was calculated by dividing the
amount of infectious virus released into the medium by the total virus yield.
RESULTS
BHV-1 induces PCD in cultured MDBK cells. Although
BHV-1 induces PCD in lymphoid cells (31, 32), it is not clear
whether infection of permissive fibroblasts or cells of epithelial
origin leads to PCD. The most commonly used markers of
PCD are (i) fragmentation of chromosomal DNA into oligo-
nucleosomal fragments, which can be detected by TUNEL
assays or by agarose gel electrophoresis, and (ii) chromatin
condensation, which is identified by DNA staining agents,
Hoechst stain, or DAPI (49,6-diamidino-2-phenylindole), for
example (29). In addition, cell viability was assessed by trypan
blue exclusion.
TUNEL-positive infected cells, but no TUNEL-positive
mock-infected cells, were readily detected at 48 h p.i. (Fig. 1).
Condensed chromatin, as judged by Hoechst 33342 staining,
was also detected in many infected cells but not in mock-
infected cells (Fig. 1). In mock-infected cells, chromatin was
diffusely stained, whereas staining in infected cells was punc-
tate and marginated. Chromatin condensation was observed in
3 to 5% of infected cells at 24 h p.i. and increased at 36 and
48 h p.i. Since previous studies demonstrated that inactivated
BHV-1 initiates PCD in PBMC (30), we tested whether inac-
tivated virus could induce PCD in MDBK cells. In contrast to
the case for PBMC, we were unable to detect higher levels of
PCD after inactivated virus was added to MDBK cells (Fig. 2).
Regardless of whether the virus was inactivated by Psoralen
cross-linking or boiling, chromatin condensation was not read-
ily detected at 48 h p.i.
High-molecular-weight DNA prepared from cells infected
for 48 h was degraded and exhibited the characteristic ladder-
ing observed after PCD (Fig. 3A). Degraded DNA was not
readily detected in mock-infected cells or in cells infected for
24 h. As expected, the percentage of viable cells decreased as
a function of time as determined by using trypan blue to mon-
itor viable cells (Fig. 3B). Taken together, these studies indi-
cated that PCD occurred in MDBK cells during the late stages
of infection.
Examination of p53 after infection. The p53 protein inhibits
cell cycle progression after DNA damage, thus facilitating
DNA repair (69), or it can induce PCD if extensive DNA
damage occurs (97). During p53-dependent PCD, p53 levels
generally increase (reviewed in reference 2). Although steady-
state levels of p53 protein were not dramatically induced after
infection (Fig. 4A), higher levels of 35S-labeled p53 protein
were present at 24 or 36 h p.i. (Fig. 4B). The antibody used for
immunoprecipitation recognizes wild-type p53 but not mutated
forms, suggesting that MDBK cells contain wild-type p53.
Compared to actin RNA levels, p53 RNA levels were slightly
higher at 24 h p.i. (Fig. 4C). At 36 h p.i., a sixfold increase in
p53 promoter activity (p53CAT) was observed (Fig. 4D). In
contrast, the simian virus 40 early promoter (pA10CAT) was
not stimulated during the late stages of infection.
Overexposure of p53 Western blots revealed a band that
migrated with an apparent molecular mass of 40 kDa at 48 h
p.i. (Fig. 5). The 40-kDa band was detected in several different
experiments. Following DNA damage, p53 binds specifically to
damaged DNA and is cleaved into 40- and 50-kDa products
FIG. 5. Cleavage of p53 after infection. Western blot analysis of p53 with
extracts prepared from mock-infected (lane M) or infected (24, 36, or 48 h p.i.)
cells is shown. The blots were probed with an antibody that detects the N
terminus of p53 (Pab 240). Cleaved products are designated p50 and p40. The
numbers to the left represent the positions of protein markers (in kilodaltons).
FIG. 6. Analysis of p21Waf1/Cip1 and Bax after infection. (A) Whole-cell ly-
sate was prepared from mock-infected cells (lane M) or infected cells (24, 36, or
48 h p.i.), and Western blot analysis was performed with an antibody which
specifically recognizes Bax or p21. Arrows indicate the positions of the respective
proteins. The numbers to the left represent the positions of protein markers (in
kilodaltons). (B) A human p21Waf1 promoter construct (pWWPCAT) was co-
transfected with pSV2-b-gal into MDBK cells with Superfect transfection re-
agent from Qiagen. Twenty-four hours after transfection, cells were infected with
5 PFU/cell. Cells were harvested at the indicated times p.i., and CAT activity was
measured. The amount of extract used to measure CAT activity was adjusted
based on b-gal activity in the respective samples. Ac-CM, acetylated chloram-
phenicol.
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(p40 or p50, respectively) (61). Cleavage of p53 occurs at the C
terminus by autoproteolysis and is important for p53-depen-
dent PCD. In summary, these studies demonstrated that infec-
tion increased p53 protein levels slightly and that p53 was
cleaved.
Examination of Bax, Bcl-2, and p21Waf1/Cip1 after infection.
Several genes that regulate the cell cycle or apoptosis are
transactivated by p53. These include the genes encoding
p21Waf1/Cip1 (21), GADD45 (40), Mdm2 (62), cyclin G (60),
and Bax (53). Since p53 protein expression increased after
infection, the levels of the p21 and Bax proteins were examined
by Western blot analysis. Bax and p21Waf1/Cip1 levels increased
as a function of time after infection (Fig. 6A). Following in-
fection, the p21Waf1/Cip1 promoter (pWWPCAT) was activated
more than 30-fold (Fig. 6B), which agreed with an increase in
p21Waf1/Cip1 protein levels.
In contrast to that of Bax and p21Waf1/Cip1, expression of the
antiapoptotic protein Bcl-2 is negatively regulated by p53 (54).
Bcl-2 protein levels in infected cells were slightly lower at 36 or
48 h p.i. than those in mock-infected cells (Fig. 7B). To confirm
that Bcl-2 expression was repressed after infection, RNA PCR
analysis was performed with total RNA prepared from mock-
infected cells or cells infected with BHV-1. A 268-bp fragment
corresponding to the Bcl-2 amplified product was detected in
mock-infected cells but was not readily detected at 24, 36, or
48 h p.i. (Fig. 7A). As expected, actin RNA and protein levels
were not altered dramatically. These studies demonstrated that
Bax and p21Waf1/Cip1 were induced after infection but that
Bcl-2 levels decreased.
Proteins that are cleaved during PCD undergo proteolysis
after infection. Caspases are cysteine proteases that play a
pivotal role in PCD (65). Caspases 2, 3, and 7 are activated by
cleavage during p53-dependent PCD (9, 45, 71). To test wheth-
er infection led to cleavage of caspase 2, an antibody that
recognizes intact caspase 2 and its 12-kDa cleavage product
FIG. 7. Analysis of Bcl-2 after infection. (A) RNA PCR analysis of Bcl-2 or actin mRNA in mock-infected cells (lane M) or infected cells (24, 36, or 48 h p.i.). Three
micrograms total RNA was reverse transcribed with Superscript reverse-transcriptase, and the cDNA was amplified by PCR. Numbers on the left are the positions of
fX174 DNA digested with HaeIII (base pairs). (B) Whole-cell lysate was prepared from mock-infected cells (lane M) or infected cells (24, 36, or 48 h p.i.), and Western
blot analysis was performed with an antibody which specifically recognized Bcl-2 or actin. The arrows indicate the position of Bcl-2 or actin. The numbers to the left
represent the positions of protein markers (in kilodaltons).
FIG. 8. Analysis of caspase 2 after infection. Whole-cell lysate was prepared
from mock-infected cells (lane M) or infected cells (24, 36, or 48 h p.i.), samples
were electrophoresed in a 12.5% gel, and Western blot analysis was performed
with an antibody which specifically recognizes caspase 2. The arrow at 12 kDa
indicates the cleaved form of caspase 2, and the one at 51 kDa shows the location
of intact caspase 2. Molecular mass markers are indicated on the left and are
expressed as kilodaltons.
FIG. 9. Cleavage of PARP, Bcl-xL, and actin after infection. Whole-cell ly-
sate was prepared from mock-infected cells (lanes M) or infected cells (24, 36, or
48 h p.i.), and Western blot analysis was performed with an antibody which spe-
cifically recognized PARP (A), Bcl-xL (B), or b-actin (C). The arrows indicate
the positions of the respective cleaved proteins, and the ovals indicate the intact
proteins.
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was utilized. At 36 or 48 h p.i., an increase in the 12-kDa
cleavage product was detected (Fig. 8).
To determine whether other caspase substrates were cleaved
following infection, Western blot analysis was performed with
antibodies directed against Bcl-xL, actin, or PARP. The Bcl-xL
gene encodes two distinct proteins as a result of alternative
splicing, a long form (Bcl-xL) and a short form (Bcl-xS (4).
Bcl-xL inhibits apoptosis, but Bcl-xS antagonizes the antiapo-
ptotic action of Bcl-xL and Bcl-2 (51). Bcl-xL is cleaved during
PCD by caspases (12). Actin is cleaved by caspase 3, and this
appears to occur after cleavage of PARP (50). At 36 or 48 h
p.i., cleavage of PARP was detected (Fig. 9A). Cleavage of
Bcl-xL and actin was detected at 48 h p.i. (Fig. 9B and C). Thus,
cleavage of caspase 2, PARP, actin, and Bcl-xL occurred during
the late stages of infection, suggesting that the caspase cascade
was activated.
Inhibition of caspases delays BHV-1-induced cytopatho-
genic effects but enhances total virus yield. To determine if
caspases play a role during infection, MDBK cells were treated
with caspase inhibitors at 6 h p.i., and the degree of cytopa-
thology was monitored by light microscopy. For these studies,
three different classes of caspase inhibitors were tested: (i)
Z-VAD-FMK, which inhibits caspase 1-like proteases and pre-
vents apoptosis mediated by a variety of stimuli (7, 80); (ii)
Ac-YVAD-CHO, which inhibits interleukin-1b-converting en-
zyme (83); and (iii) Z-DEVD-FMK, which inhibits caspase
3-like enzymes (59). Since adherence of infected cells to the
tissue culture dish is a reliable marker for viability of BHV-1-
infected MDBK cells, we used this as a means to estimate what
role, if any, caspase inhibitors played during infection. Relative
to untreated infected cultures or cultures which were infected
and treated with DMSO, more cells were attached to the plate
when cultures were treated with Z-VAD-FMK at 48 h p.i. (Fig.
10). Although Z-DEVD-FMK or Ac-YVAD-CHO treatment
increased the number of cells attached to plastic after infec-
tion, the effect was not as dramatic as that with Z-VAD-FMK.
Furthermore, addition of all three caspase inhibitors did not
dramatically enhance the protective effect. If cultures were
incubated for longer periods of time, all cells were eventually
released from the substrate and were not viable (20). The
simplest explanation of this study was that caspases were not
absolutely required for virus infection.
To test whether inhibition of caspases by Z-VAD-FMK
treatment had an effect on virus release, the amount of virus
released from infected cells was measured in cultures treated
with Z-VAD-FMK and compared to that for untreated cul-
tures. Since Z-VAD-FMK has a short half-life (14) and the
medium obtained from infected cells was diluted more than
1,000-fold for measuring virus, it was unlikely that residual
levels of Z-VAD-FMK were active or affected the study. When
cultures were subjected to three cycles of freeze-thawing (270
to 37°C) to estimate the total amount of virus in infected cells,
a twofold increase in virus titers was observed following treat-
ment with Z-VAD-FMK (Fig. 11B). Twofold-less virus was
present in the medium that was removed at 48 h p.i. when cells
were treated with Z-VAD-FMK (Fig. 11A). In summary, these
studies suggested that Z-VAD-FMK treatment enhanced the
amount of total infectious virus but reduced or delayed virus
release.
In vitro reconstitution of PCD. Experiments were per-
formed to confirm the importance of caspases during virus-
induced PCD and to prove that the components necessary to
initiate PCD of healthy nuclei were present in infected cells.
Several studies have demonstrated that cell extracts prepared
from cells undergoing PCD mimic the intracellular environ-
ment of a dying cell and thus can induce nuclear changes which
are observed during PCD (chromatin condensation or DNA
laddering, for example) (34, 44, 58). Cell extract was prepared
from infected cells (24, 36, or 48 h p.i.) and added to nuclei
prepared from uninfected cells, and alterations in nuclear
FIG. 10. Z-VAD-FMK delays cell death after infection. The indicated caspase inhibitor (25 mM) was added at 6 and 24 h p.i. Representative areas of the cultures
were photographed (magnification, 3200) at 48 h p.i. Since the caspase inhibitors were suspended in DMSO, a control experiment was performed to test the effects
of DMSO on PCD.
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DNA were monitored by Hoechst 33342 staining. Nuclei from
CV-1 cells were used because these cells have a low frequency
of PCD when actively growing and because CV-1 cells are not
permissive for BHV-1 infection. Incubation of healthy CV-1
nuclei with extract prepared from BHV-1-infected cells (24, 36,
or 48 h p.i.) induced chromatin condensation (Fig. 12). A high-
er percentage of nuclei contained condensed chromatin when
the nuclei were incubated with extracts prepared from cells
infected for 48 versus 24 h p.i. The same extract prepared from
mock-infected cells did not efficiently induce chromatin con-
densation. Incubation of the extract prepared from infected
cells (48 h p.i.) with Z-VAD-FMK inhibited chromatin con-
densation. These studies indicated that extract prepared from
infected cells can induce chromatin condensation of nuclei
prepared from nonpermissive cells and that active caspases
play a role during this process.
DISCUSSION
Although PCD occurred in MDBK cells after infection, in-
activated virus did not efficiently induce PCD (Fig. 2). This
finding is in contrast to those from previous studies using
PBMC (30–32) or activated CD41 T cells (24). In general,
lymphoid cells are prone to PCD, whereas fibroblasts or epi-
thelial cells are more resistant (90), suggesting that inactivated
virus can induce PCD in cells which easily undergo PCD. It is
also possible that novel virus-host interactions may be impor-
tant for inactivated virus to initiate PCD in lymphocytes. For
example, a novel member of the tumor necrosis factor (TNF)
NGF receptor family (HVEM) (56) mediates HSV-1 entry into
activated T cells. Conversely, entry of HSV-1 and BHV-1 into
epithelial or other nonlymphoid cells is mediated by an unre-
lated membrane glycoprotein which resembles the poliovirus
receptor (27). If BHV-1 entry into PBMC is mediated by
binding of a viral glycoprotein to a TNF-like receptor, this
interaction could lead to PCD in the absence of active infec-
tion, because binding of ligand to TNF receptors can initiate
PCD (reviewed in references 26, 82a, and 91). Since PCD was
not observed until late after infection, the early events of pro-
ductive infection may inhibit PCD, as previously described for
HSV-1 (43). The possibility that BHV-1 encodes positive and
negative regulators of PCD supports the hypothesis that cell-
type-specific interactions are important during PCD.
The levels of newly synthesized p53 protein and promoter
activity increased after infection (Fig. 4), suggesting that p53
plays a role in virus-induced PCD. Genes that are regulated by
p53 (those for Bax, p21Waf1/Cip1, and Bcl-2, for example) were
also induced or repressed in a p53-dependent fashion (Fig. 6
and 7). Cleavage of p53 occurs in response to DNA damage,
FIG. 11. Z-VAD-FMK enhances virus yield but reduces virus release at 48 h p.i. Z-VAD-FMK (25 mM) was added to cultures 6 and 24 h p.i. Cells were removed
from the dish at 48 h p.i. (A) Cell-free virus release was measured by collecting the medium from infected cells at 48 h p.i. after removal of cells by centrifugation. (B)
Cells plus culture medium were subjected to three freeze-thaw cycles (270 to 37°C), and cells were removed by centrifugation. The amount of infectious virus was
measured as described in Materials and Methods. Data are the means and standard deviations from three independent experiments. TCID50, 50% tissue culture
infective dose.
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generating p50 or p40 (55), and consequently alters the tran-
scriptional regulatory activity of p53 (11, 36, 37). HSV-1 and
HSV-2 induce DNA damage after infection (64, 74), suggest-
ing that infection by BHV-1 leads to DNA damage and p53
induction. E1A, E2F-1, or c-Myc can also sensitize cells to
undergo p53-dependent PCD (3, 7, 18, 26, 46, 66, 94). Myc-
mediated PCD may have relevance to BHV-1 infection, be-
cause c-Myc levels are elevated after infection (20, 31). Despite
the findings that link p53 to BHV-1-induced PCD, p53-inde-
pendent mechanisms may also be important. This hypothesis is
supported by the finding that p53 induction was modest com-
pared to induction by adenovirus infection (82) and that ade-
novirus infection induces PCD by p53-dependent and -inde-
pendent mechanisms (82, 82a). A p532/2 primary bovine cell
line is not available, making it difficult to directly address this
issue.
The importance of caspase activation during PCD is well
established (87). The finding that caspase 2 is cleaved after
infection indicated that caspases are activated. A number of
substrates for caspases have been identified: protein kinases (8,
23), Rb (38), Sp1 (63), Bcl-2 (12), ICAD (73), Bcl-xL (16), and
cytoskeletal proteins (lamin B1 and actin) (5, 9, 50). Bcl-xL
protects cells from p53-dependent PCD (51, 76), and cleavage
of Bcl-xL inactivates this function or induces PCD (16), sug-
gesting that cleavage of Bcl-xL after infection is important.
Although cleavage of PARP, Bcl-xL, and actin occurred after
infection, cleavage of PARP was detected earlier. In general,
PARP cleavage is an early event during PCD, while cytoplas-
mic proteins are necessary for maintaining the structural in-
tegrity of the cell and thus are cleaved later (25, 91).
PCD is an important host cell defense that limits viral in-
fection. Prevention of PCD enhances production of human
immunodeficiency virus (13), simian immunodeficiency virus
(10), and adenoviruses (14). Conversely, induction of PCD by
specific viral genes near the end of infection may promote
cell-to-cell spread and virus release and interfere with inflam-
matory responses. The adenovirus E3 gene promotes virus
release and enhances virus growth in cultured cells by promot-
ing cell death that is distinct from PCD (85). The finding that
Z-VAD-FMK enhanced total infectious virus production at
48 h p.i. implied that prevention of PCD enhanced virus yield.
Since virus release was reduced at 48 h p.i. when cells were
treated with Z-VAD-FMK (Fig. 10), we hypothesized that
caspase activation or other events during PCD led to virus
assembly or release. Infection of cattle typically leads to upper
respiratory tract infections and transient immunosuppression,
thus allowing opportunistic bacterial infections (reviewed in
reference 84). If extensive lymphocyte PCD occurs after infec-
tion, immunosuppression would occur. PCD of nonlymphoid
cells in the upper respiratory tract could also lead to virus
spread and interfere with an inflammatory response. To un-
derstand the role that PCD plays with respect to BHV-1 patho-
genesis, it will be necessary to determine what cell types un-
dergo PCD in infected cattle and correlate these findings to
symptoms associated with infection.
FIG. 12. Extracts prepared from infected cells induce chromatin condensation. Nuclei prepared from CV-1 cells (2 3 105) were incubated with 75 mg of extract
prepared from mock-infected or infected cells. For caspase inhibition, 25 mM Z-VAD-FMK was added prior to addition of nuclei. Nuclei were incubated with the
respective cell extracts for 2 h at 37°C. Nuclei were stained with Hoechst 33342 as described in Materials and Methods, and the samples were observed under a UV
microscope. Magnification, 3400.
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